Beijing Tiantan Biological Products Co., Ltd. Stock price
Equities
600161
CNE000000WF9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.5 CNY | -1.92% | -5.76% | -17.58% |
Sales 2023 * | 5.24B 724M | Sales 2024 * | 6.2B 857M | Capitalization | 42.84B 5.93B |
---|---|---|---|---|---|
Net income 2023 * | 1.12B 155M | Net income 2024 * | 1.38B 191M | EV / Sales 2023 | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 6.91 x |
P/E ratio 2023 * |
38.2
x | P/E ratio 2024 * |
31
x | Employees | 4,568 |
Yield 2023 * |
0.6% | Yield 2024 * |
0.4% | Free-Float | 44.48% |
1 day | -0.57% | ||
1 week | -3.92% | ||
Current month | -8.13% | ||
1 month | -6.14% | ||
3 months | -15.56% | ||
6 months | +0.62% | ||
Current year | -15.97% |
Managers | Title | Age | Since |
---|---|---|---|
Dao Xing Fu
CEO | Chief Executive Officer | 60 | 17-04-24 |
Hui Chuan Yang
CHM | Chairman | 57 | 11-05-31 |
Bo Tian
IRC | Investor Relations Contact | - | 06-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yan Fang
BRD | Director/Board Member | 56 | 20-06-22 |
Hui Chuan Yang
CHM | Chairman | 57 | 11-05-31 |
Fen Ling Gu
BRD | Director/Board Member | 61 | 20-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.66% | 2 M€ | -16.04% | - | |
0.61% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 25.5 | -1.92% | 12 528 180 |
24-03-27 | 26 | -0.57% | 7,019,324 |
24-03-26 | 26.15 | +0.58% | 6,821,902 |
24-03-25 | 26 | -0.69% | 7,498,190 |
24-03-22 | 26.18 | -1.50% | 8,940,636 |
End-of-day quote Shanghai S.E., March 26, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.97% | 5.93B | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
+44.30% | 23.35B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B |